Literature DB >> 29689165

The Taxonomy of Covalent Inhibitors.

Alfred Tuley1, Walter Fast1.   

Abstract

Covalent enzyme inhibitors are widely applied as biochemical tools and therapeutic agents. As a complement to categorization of these inhibitors by reactive group or modification site, we present a categorization by mechanism, which highlights common advantages and disadvantages inherent to each approach. Established categories for reversible and irreversible covalent inhibition are reviewed with representative examples given for each class, including covalent reversible inhibitors, slow substrates, residue-specific reagents, affinity labels (classical, quiescent, and photoaffinity), and mechanism-based inactivators. The relationships of these categories to proteomic profiling probes (activity-based and reactivity-based) as well as complementary approaches such as prodrug and soft drug design are also discussed. A wide variety of strategies are used to balance reactivity and selectivity in the design of covalent enzyme inhibitors. Use of a shared terminology is encouraged to clearly convey these mechanisms, to relate them to prior use of covalent inhibitors in enzymology, and to facilitate the development of more effective covalent inhibitors.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29689165      PMCID: PMC6016374          DOI: 10.1021/acs.biochem.8b00315

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  68 in total

1.  Activity-based protein profiling: the serine hydrolases.

Authors:  Y Liu; M P Patricelli; B F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  On the mechanism of dimethylarginine dimethylaminohydrolase inactivation by 4-halopyridines.

Authors:  Corey M Johnson; Arthur F Monzingo; Zhihong Ke; Dae-Wi Yoon; Thomas W Linsky; Hua Guo; Jon D Robertus; Walter Fast
Journal:  J Am Chem Soc       Date:  2011-06-23       Impact factor: 15.419

3.  SCH28080 prevents omeprazole inhibition of the gastric H+/K+-ATPase.

Authors:  S J Hersey; L Steiner; J Mendlein; E Rabon; G Sachs
Journal:  Biochim Biophys Acta       Date:  1988-08-31

Review 4.  Designed covalent allosteric modulators: an emerging paradigm in drug discovery.

Authors:  Shaoyong Lu; Jian Zhang
Journal:  Drug Discov Today       Date:  2016-11-22       Impact factor: 7.851

Review 5.  Residue-Specific Peptide Modification: A Chemist's Guide.

Authors:  Justine N deGruyter; Lara R Malins; Phil S Baran
Journal:  Biochemistry       Date:  2017-07-17       Impact factor: 3.162

Review 6.  Site-selective covalent reactions on proteinogenic amino acids.

Authors:  Wing Ho So; Yu Zhang; Wei Kang; Clarence T T Wong; Hongyan Sun; Jiang Xia
Journal:  Curr Opin Biotechnol       Date:  2017-07-05       Impact factor: 9.740

7.  Inactivation of microbial arginine deiminases by L-canavanine.

Authors:  Ling Li; Zhimin Li; Danqi Chen; Xuefeng Lu; Xiaohua Feng; Elizabeth C Wright; Nathan O Solberg; Debra Dunaway-Mariano; Patrick S Mariano; Andrey Galkin; Liudmila Kulakova; Osnat Herzberg; Kari B Green-Church; Liwen Zhang
Journal:  J Am Chem Soc       Date:  2008-01-19       Impact factor: 15.419

Review 8.  Designing Irreversible Inhibitors--Worth the Effort?

Authors:  Concepción González-Bello
Journal:  ChemMedChem       Date:  2015-11-23       Impact factor: 3.466

9.  An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site.

Authors:  Fernando L Rock; Weimin Mao; Anya Yaremchuk; Mikhail Tukalo; Thibaut Crépin; Huchen Zhou; Yong-Kang Zhang; Vincent Hernandez; Tsutomu Akama; Stephen J Baker; Jacob J Plattner; Lucy Shapiro; Susan A Martinis; Stephen J Benkovic; Stephen Cusack; M R K Alley
Journal:  Science       Date:  2007-06-22       Impact factor: 47.728

10.  Design of reversible, cysteine-targeted Michael acceptors guided by kinetic and computational analysis.

Authors:  Shyam Krishnan; Rand M Miller; Boxue Tian; R Dyche Mullins; Matthew P Jacobson; Jack Taunton
Journal:  J Am Chem Soc       Date:  2014-09-02       Impact factor: 15.419

View more
  21 in total

1.  Development of a Suicide Inhibition-Based Protein Labeling Strategy for Nicotinamide N-Methyltransferase.

Authors:  Sudeshna Sen; Santanu Mondal; Li Zheng; Ari J Salinger; Walter Fast; Eranthie Weerapana; Paul R Thompson
Journal:  ACS Chem Biol       Date:  2019-04-05       Impact factor: 5.100

2.  Medicinal Chemistry: From Targets to Therapies.

Authors:  Bruce E Maryanoff; Peter Wipf
Journal:  ACS Med Chem Lett       Date:  2019-07-11       Impact factor: 4.345

Review 3.  Reactive-cysteine profiling for drug discovery.

Authors:  Aaron J Maurais; Eranthie Weerapana
Journal:  Curr Opin Chem Biol       Date:  2019-03-18       Impact factor: 8.822

4.  Covalent Antiviral Agents.

Authors:  Sako Mirzaie; Fatemeh Abdi; Amin GhavamiNejad; Brian Lu; Xiao Yu Wu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  A Lysine-Targeted Affinity Label for Serine-β-Lactamase Also Covalently Modifies New Delhi Metallo-β-lactamase-1 (NDM-1).

Authors:  Pei W Thomas; Michael Cammarata; Jennifer S Brodbelt; Arthur F Monzingo; R F Pratt; Walter Fast
Journal:  Biochemistry       Date:  2019-06-07       Impact factor: 3.162

6.  Dissection, Optimization, and Structural Analysis of a Covalent Irreversible DDAH1 Inhibitor.

Authors:  Gayle Burstein-Teitelbaum; Joyce A V Er; Arthur F Monzingo; Alfred Tuley; Walter Fast
Journal:  Biochemistry       Date:  2018-07-20       Impact factor: 3.162

7.  Precision Targeting of Endogenous Epidermal Growth Factor Receptor (EGFR) by Structurally Aligned Dual-Modifier Labeling.

Authors:  Ivan de Jesus Salazar-Estrada; Karthik Shantharam Kamath; Fei Liu
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-19

8.  Detection of an enzyme isomechanism by means of the kinetics of covalent inhibition.

Authors:  S A Adediran; Michael J Morrison; R F Pratt
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2021-06-02       Impact factor: 4.125

9.  Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds.

Authors:  Anh-Tien Ton; Francesco Gentile; Michael Hsing; Fuqiang Ban; Artem Cherkasov
Journal:  Mol Inform       Date:  2020-03-23       Impact factor: 4.050

10.  α-Methylene-β-Lactone Scaffold for Developing Chemical Probes at the Two Ends of the Selectivity Spectrum.

Authors:  Lei Wang; Louis P Riel; Bekim Bajrami; Bin Deng; Amy R Howell; Xudong Yao
Journal:  Chembiochem       Date:  2020-11-11       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.